Amphastar Pharmaceuticals, Inc.
AMPH
$28.89
$0.07920.28%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.10% | 6.54% | -12.11% | 19.38% | -26.52% |
| Total Depreciation and Amortization | 1.60% | 2.04% | 1.30% | 1.26% | 1.61% |
| Total Amortization of Deferred Charges | -2.69% | -69.46% | 14.47% | -26.95% | -44.38% |
| Total Other Non-Cash Items | -234.71% | 96.55% | 80.78% | 245.49% | -210.35% |
| Change in Net Operating Assets | -17.24% | -184.85% | 218.86% | 72.84% | -365.62% |
| Cash from Operations | -51.60% | -13.24% | 24.99% | 131.69% | -62.91% |
| Capital Expenditure | 10.02% | -128.21% | 31.26% | 6.87% | 7.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.90% | -131.92% | 171.08% | 125.67% | -508.55% |
| Cash from Investing | -3.16% | 50.52% | -558.77% | 114.79% | -230.79% |
| Total Debt Issued | -48.80% | 38,132.00% | -100.61% | -- | -100.00% |
| Total Debt Repaid | -180.49% | 99.49% | -8,072.45% | 99.80% | 74.93% |
| Issuance of Common Stock | -- | -- | -- | -- | 67.45% |
| Repurchase of Common Stock | -21.84% | -1,081.36% | 84.50% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 103.75% | -58,800.00% | 100.40% | 48.68% | 95.30% |
| Cash from Financing | -48.33% | -112.92% | 21.08% | 71.16% | -154.36% |
| Foreign Exchange rate Adjustments | 82.54% | -231.58% | 80.41% | 59.24% | -526.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,722.23% | 121.66% | -120.28% | 144.94% | -205.64% |
